Skip to content

Estradiol and Intrusive Memories

The Effect of Estradiol on the Acquisition and Consolidation of Trauma-Associated Memories

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07419594
Acronym
EstraMemo
Enrollment
273
Registered
2026-02-19
Start date
2024-08-19
Completion date
2028-02-29
Last updated
2026-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrusion, Intrusion Symptom, Intrusive Memories, PTSD, Trauma

Keywords

Trauma film, Estradiol, ptsd, intrusive memories, intrusion, estrogen

Brief summary

The aim of the current project is to investigate the impact of 3mg of oral estradiol valerate on the formation of intrusive memories after analog trauma. A well-established stress-film paradigm will be used to induce intrusive symptoms in healthy participants. In a double-blind placebo-controlled study, the impact of oral estradiol on intrusive symptoms during and immediately after exposure to a trauma film will be examined. The primary hypothesis is that exogenous oral estradiol will decrease the number of intrusive memories recorded in the four days following experimental trauma compared with placebo controls. This project will contribute to the current understanding of intrusive memory formation in PTSD and may guide the development of future pharmacological preventions.

Interventions

DRUGEstradiol Valerate

3mg of Estradiol Valerate pills, administred orally

DRUGPlacebo

Plabo pill

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Masking description

Double Blind, randomized, placebo controlled

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy female volunteers * German on B1 level

Exclusion criteria

* former or present disorder according to the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) * any physical illnesses * any medication intake (except oral contraceptive) * history of traumatic experience, e.g. history of sexual abuse or rape * pregnancy or lactation period * intake of oral contraceptives * follicular phase of menstrual cycle

Design outcomes

Primary

MeasureTime frameDescription
Change of Intrusive Memories in the following four days after the interventionfour consecutive daysInfluence of estradiol on the development of intrusive memories measured with an intrusion diary

Secondary

MeasureTime frameDescription
Noradrenergic System (measured with salivary alpha-amylase - u/ml)Day 1Influence of noradrenergic system measured with salivary alpha-amylase on the development of intrusive memories
Hypothalamic-pituitary-adrenal (HPA) axis (measured with salivary cortisol - nmol/L)Day 1Influence of HPA-axis measured with salivary cortisol on the development of intrusive memories
Estradiol and ProgesteroneDay 1Influence of salivary endogenous estradiol and progesterone on the development of intrusive memories.
heart rate variabilityDay 1Influence of heart rate variability on the development of intrusive memories

Countries

Germany

Contacts

CONTACTTolou Maslahati, M.Sc.
tolou.maslahati@charite.de0049 30 450 517 567
PRINCIPAL_INVESTIGATORKatja Wingenfeld, Prof. Dr.

Charite University, Berlin, Germany

PRINCIPAL_INVESTIGATORStefan Roepke, Prof. Dr.

Charite University, Berlin, Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026